Award funding belongs to the NIH-funded project. It does not represent money allocated to the provider, proof of procurement, vendor selection, or confirmed buying intent.
Best opportunity
The strongest ranked opportunity in full.
94fit
DIRECTRank #1TIER A EXPLICIT
Radiation Effect on Immune Cells and the Microbiome
WEILL MEDICAL COLL OF CORNELL UNIV · NEW YORK, NY
Principal investigator
LAURA SANTAMBROGIO
NIH project
5U54CA274291-05
Award notice
Aug 14, 2026
Award amount
$333,385
Bounded planned-work evidence
Using single cell RNA-sequencing and spatial transcriptomics, we will generate a road map of the effects of RT on the different immune cell types.
Why it matches the confirmed capability
SINGLE CELL RNA SEQ: The project explicitly plans single-cell RNA sequencing and spatial transcriptomics, matching a confirmed single-cell RNA-seq service capability.
Commercial relevance
The public project record describes a workflow compatible with the confirmed service capability. Approach only with the evidence shown here and without assuming a purchase decision.
What this does not prove
This funded-project evidence does not prove procurement, vendor selection, buying intent, or budget earmarked for a provider.
WEILL MEDICAL COLL OF CORNELL UNIV Radiation Effect on Immune Cells and the Microbiome
DIRECT
$333,385
Aug 14, 2026
TIER A EXPLICIT
2
COLUMBIA UNIVERSITY HEALTH SCIENCES Functional significance of plasma cell infiltrates of human cardiac allograft vasculopathy
DIRECT
$728,396
Aug 14, 2026
TIER A EXPLICIT
3
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Cryptic exons and TDP-43 neurodegeneration in Alzheimer’s and multietiology dementias
PLAUSIBLE
$1,871,212
Aug 14, 2026
TIER A EXPLICIT
Full opportunity details
Evidence, fit, and limitations for every opportunity.
94fit
DIRECTRank #1TIER A EXPLICIT
Radiation Effect on Immune Cells and the Microbiome
WEILL MEDICAL COLL OF CORNELL UNIV · NEW YORK, NY
Principal investigator
LAURA SANTAMBROGIO
NIH project
5U54CA274291-05
Award notice
Aug 14, 2026
Award amount
$333,385
Bounded planned-work evidence
Using single cell RNA-sequencing and spatial transcriptomics, we will generate a road map of the effects of RT on the different immune cell types.
Why it matches the confirmed capability
SINGLE CELL RNA SEQ: The project explicitly plans single-cell RNA sequencing and spatial transcriptomics, matching a confirmed single-cell RNA-seq service capability.
Commercial relevance
The public project record describes a workflow compatible with the confirmed service capability. Approach only with the evidence shown here and without assuming a purchase decision.
What this does not prove
This funded-project evidence does not prove procurement, vendor selection, buying intent, or budget earmarked for a provider.
Functional significance of plasma cell infiltrates of human cardiac allograft vasculopathy
COLUMBIA UNIVERSITY HEALTH SCIENCES · NEW YORK, NY
Principal investigator
Emmanuel Zorn
NIH project
5R01AI184963-02
Award notice
Aug 14, 2026
Award amount
$728,396
Bounded planned-work evidence
Aim 1 will combine IGHV repertoire and single-cell-RNA-seq analyses to determine the clonal composition and transcriptome profile of plasma cells.
Why it matches the confirmed capability
SINGLE CELL RNA SEQ: The project explicitly states a single-cell RNA-seq analysis plan, which is compatible with the confirmed workflow.
Commercial relevance
The public project record describes a workflow compatible with the confirmed service capability. Approach only with the evidence shown here and without assuming a purchase decision.
What this does not prove
This funded-project evidence does not prove procurement, vendor selection, buying intent, or budget earmarked for a provider.
Cryptic exons and TDP-43 neurodegeneration in Alzheimer’s and multietiology dementias
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · CORAL GABLES, FL
Principal investigator
Keith A Josephs
NIH project
2RF1NS120992-04
Award notice
Aug 14, 2026
Award amount
$1,871,212
Bounded planned-work evidence
RNA sequencing from the amygdala – a TDP-43-relevant region – will be expanded and integrated to identify genetic variants associated with TDP-43 dysfunction.
Why it matches the confirmed capability
GENERAL CONVENTIONAL RNA SEQ SERVICE: The project explicitly plans RNA sequencing, while the public abstract does not establish the exact service configuration required.
Commercial relevance
The public project record describes a workflow compatible with the confirmed service capability. Approach only with the evidence shown here and without assuming a purchase decision.
What this does not prove
This funded-project evidence does not prove procurement, vendor selection, buying intent, or budget earmarked for a provider.
Start with the strongest evidence-backed opportunity.
This editable brief is generated deterministically from the retained report evidence; it does not claim procurement or buying intent.
Methodology and limitations
Confirmed product capabilities are compared with public NIH-funded project workflow evidence from the stated search window. DIRECT means the retained project evidence and confirmed capability are compatible under the workflow pack. PLAUSIBLE means the evidence remains useful but is less exact. LabsIntent does not prove procurement, vendor selection, intent, or earmarked budget.
Data source: NIH RePORTER. Workflow pack: RNA-seq services v1.6. Corpus/retrieval timestamp: Aug 18, 2026.